Cisplatin and vinorelbine chemotherapy in recurrent vulvar carcinoma

Oncology

Volumn 77, Issue 5, 2009, Pages 281-284

  Cormio, Gennaro ^a   Loizzi, Vera ^a   Gissi, Francesca ^a   Serrati, Giuseppe ^a   Panzarino, Mariantonietta ^a   Carriero, Carmine ^a   Selvaggi, Luigi ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Chemotherapy; Cisplatin; Vinorelbine; Vulvar cancer

Indexed keywords

CISPLATIN; DEXAMETHASONE; FUROSEMIDE; GABAPENTIN; GRANULOCYTE COLONY STIMULATING FACTOR; NAVELBINE; ONDANSETRON;

ACUTE KIDNEY FAILURE; ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DRUG ACTIVITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FEMALE; HUMAN; INGUINAL REGION; LEUKOPENIA; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; NEUROPATHIC PAIN; NEUROTOXICITY; NEUTROPENIA; OVERALL SURVIVAL; PERINEUM; PHASE 2 CLINICAL TRIAL; PHLEBITIS; PRIORITY JOURNAL; RECURRENT CANCER; SEPSIS; THROMBOCYTOPENIA; TREATMENT RESPONSE; VAGINA; VOMITING; VULVA; VULVA CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; VINBLASTINE; VULVAR NEOPLASMS;

EID: 70449669053     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000259259     Document Type: Article

References (20)

1. Jemal A, Thomas A, Murray T, Thun M: Cancer statistics, 2002. CA Cancer J Clin 2002; 52: 23-47.
2. Beller U, Sideri M, Maisonneuve P, Benedet JL, Heintz AP, Ngan HY, et al: Carcinoma of the vulva. J Epidemiol Biostat 2001; 6: 155-173.
3. Gadducci A, Cionini L, Romanini A, Fanucchi A, Genazzani AR: Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer. Crit Rev Oncol Hematol 2006; 60: 227-241.
4. Deppe G, Cohen CJ, Bruckner HW: Chemotherapy of squamous cell carcinoma of the vulva: a review. Gynecol Oncol 1979; 7: 345-348.
5. Winter R, Petru E, Pickel H: Chemotherapy in vulvar cancer; in Angioli R, Benedetti Panici P, Kavanagh JJ, Pecorelli S, Penalver M (eds): Chemotherapy for Gynecological Neoplasms. Current Therapy and Novel Approaches. New York, Marcel Dekker, 2004, pp 617-624.
6. Leveque D, Jehl F: Clinical pharmacokinetics of vinorelbine. Clin Pharmacokinet 1996; 31: 184-197.
7. Depierre A, Chastang C, Quoix E, Lebeau B, Blanchon F, Paillot N, et al: Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trial. Ann Oncol 1994; 5: 37-42.
8. Le Chevalier T, Brisgand D, Douillard JY, Pujol JL, Alberola V, Monnier A, et al: Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients. J Clin Oncol 1994; 12: 360-367.
9. Morris M, Brader KR, Levenback C, Burke TW, Atkinson EN, Scott WR, et al: Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix. J Clin Oncol 1998; 16: 1094-1098. (Pubitemid 28108745)
10. Di Vagno G, Cormio G, Pignata S, Scambia G, Di Stefano MG, Tambaro R, et al: Cisplatin and vinorelbine as neoadjuvant chemotherapy in locally advanced cervical cancer: a phase II study. Int J Gynecol Cancer 2003; 13: 308-312.
11. Pignata S, Silvestro G, Ferrari E, Selvaggi L, Perrone F, Maffeo A, et al: Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix. J Clin Oncol 1999; 17: 756-760.
12. Petterson F: 21st annual report on the results of treatment in gynecological cancer. Int J Gynecol Obstet 1991; 36(suppl 1):27-130.
13. Fleming TR: One-sample multiple testing procedure for phase II clinical trials. Biometrics 1982; 38: 143-151.
14. Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer 1981; 47: 207-214.
15. Tsavaris N, Kopterides P, Kosmas C, Efthymiou A, Skopelitis H, Dimitrakopoulos A, et al: Gabapentin monotherapy for the treatment of chemotherapy-induced neuropathic pain: a pilot study. Pain Med 2008; 9: 1209-1216.
16. Shimizu Y, Hasumi K, Masubuchi K: Effective chemotherapy consisting of bleomycin, vincristine, mitomycin C, and cisplatin (BOMP) for a patient with inoperable vulvar cancer. Gynecol Oncol 1990; 36: 423-427.
17. Durrant KR, Mangioni C, Lacave AJ, George M, van der Burg ME, Guthrie D, et al: Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: a phase II study of the EORTC Gynaecological Cancer Cooperative Group (GCCG). Gynecol Oncol 1990; 37: 359-362.
18. Wagenaar HC, Colombo N, Vergote I, Hoctin-Boes G, Zanetta G, Pecorelli S, et al: Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer. Gynecol Oncol 2001; 81: 348-354.
19. Thigpen JT, Blessing JA, Homesley HD, Lewis GC Jr: Phase II trials of cisplatin and piperazinedione in advanced or recurrent squamous cell carcinoma of the vulva: a Gynecologic Oncology Group Study. Gynecol Oncol 1986; 23: 358-363.
20. Muss HB, Bundy BN, Christopherson WA: Mitoxantrone in the treatment of advanced vulvar and vaginal carcinoma. A Gynecologic Oncology Group Study. Am J Clin Oncol 1989; 12: 142-144.